Yue Wu

Dr. Yue A. Wu is an Independent Director at Semnur Pharmaceuticals, Inc., an Independent Director at Scilex Holding Co., a President & Chief Executive Officer at Cothera Bioscience, Inc. and an Independent Director at CASI Pharmaceuticals, Inc. He is on the Board of Directors at Semnur Pharmaceuticals, Inc., Scilex Holding Co., Scilex Pharmaceuticals, Inc. and CASI Pharmaceuticals, Inc. Dr. Wu was previously employed as an Independent Director by Sorrento Therapeutics, Inc., an Independent Director by CASI Pharmaceuticals, Inc. /Old/, a Chief Operating Officer by Unimicro Technologies, Inc., a President, Chief Executive & Strategy Officer by Crown Bioscience International, a President, CEO & Chief Scientific Officer by Crown Bioscience, Inc., a Chief Business Officer by Starvax International, Inc. (China), a Head-Asian Operations by Burrill LLC, a Manager-Business Development & Strategic Planning by F.
Hoffmann-La Roche Ltd., and a Chief Business Officer by Starvax, Inc. He also served on the board at Sorrento, Inc. He received his undergraduate degree from Fudan University, a graduate degree from the University of Illinois At Urbana–Champaign, an MBA from the University of California, Berkeley and a doctorate degree from the University of California, Berkeley.